GLG News by Holistic and Alternative Medicine Specialists (US)

Sanofi's competitors have in the pipeline drugs that work similarly. This rejection is one on a string of setbacks for the innovative company, but more forthrightness about the problems would help them in the marketplace, and with physicians. Overseas markets have only partially tapped potential, which...

Ten countries have already approved the drug, and some increased side effects have been noted, but not to the magnitude reported to the FDA. Sanofi is a smart company that will regroup and make something new of this, and already is undertaking educational efforts with key physicians and scholars.

Vitamin D is emerging as one of the few vitamins that should be supplemented. Some 60 percent of the U.S. is probably deficient, from November through May. Anyone can make a mistake on live TV, but Vitamins D, E, A and K are fat soluble: they should be eaten with food with a little healthy fat to maximize...

Direct link is here: http://www.forbes.com/feeds/ap/2007/05/14/ap3717544.html This is an important case because it shows that the FDA can have some jurisdiction over supplements it deems to be dangerous, and win in Court. Physicians are frustrated with having little say in drug-supplement interactions,...

1. These excellent data apply only to men in the U.S., but that is a large and lucrative market for COPD prevention. 2. Other, less well-known conditions have also been prevented with dietary patterns and the Mediterranean Diet is one of the best studied. 3. It also has wide palate and culinary appeal...and...

In a word, they are missing innovation. This press release offers skim-the-surface-please-call-us results: the devil is in the details. A new model for diabetes disease management is needed to get employers and their employees off the dime, literally. Amazingly, this model is simple, local, personal...

A/A and Phen/Fen have disturbing similarities. Black box warnings have been shown to hurt sales, and two seem on the horizon here. Other diabetes drugs and makers are less troubled.

Cholesterol meds--older statins especially--can safely be prescribed as generic, and consumers can benefit.Financial incentives work for consumers, especially at the POS and for doctors, who do more of what they are paid well to do, like other workers.  What doesn't work for doctors are more needless...

Technology can help control health care costs in the biggest markets.This study, however, is a misuse: it is all about process and not about outcome. Not what anyone who care about health or resources should be please about.Those who want to make a difference in disease management should seek out excellent...

1. Yes, relevant: people need and want better information, and want to swim in the fountain of youth if they can, especially while drinking excellent red wine, Sideways.2. Maybe useful: the jury on resveratrol, its measurement availability in the U.S. hard-to-find, but completely available with detailed...